Cardiorenal syndrome: the emerging role of protein-bound uremic toxins
about
Animal Models to Study Links between Cardiovascular Disease and Renal Failure and Their Relevance to Human PathologyChronic Kidney Disease and Fibrosis: The Role of Uremic Retention SolutesIndoxyl sulfate (IS)-mediated immune dysfunction provokes endothelial damage in patients with end-stage renal disease (ESRD).Diuretic use in heart failure and outcomes.Decrease in irisin in patients with chronic kidney diseaseGut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney diseaseThe uremic toxin adsorbent AST-120 abrogates cardiorenal injury following myocardial infarction.Indoxyl sulfate-induced activation of (pro)renin receptor promotes cell proliferation and tissue factor expression in vascular smooth muscle cells.Soluble Klotho Protects against Uremic Cardiomyopathy Independently of Fibroblast Growth Factor 23 and Phosphate.Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxinsRandomized Placebo-Controlled EPPIC Trials of AST-120 in CKD.Increased Proinflammatory Cytokine Production and Decreased Cholesterol Efflux Due to Downregulation of ABCG1 in Macrophages Exposed to Indoxyl Sulfate.Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis PatientsApocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.Relationship between history of coronary heart disease at dialysis initiation and onset of events associated with heart disease: a propensity-matched analysis of a prospective cohort study.Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure.Hepatic sulfotransferase as a nephropreventing target by suppression of the uremic toxin indoxyl sulfate accumulation in ischemic acute kidney injury.The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy.Anti-oxidative effect of AST-120 on kidney injury after myocardial infarction.Obesity-related cardiorenal disease: the benefits of bariatric surgery.Detrimental role of humoral signalling in cardio-renal cross-talk.Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins.Sudden cardiac death in end stage renal disease: unlocking the mystery.Cellular apoptosis in the cardiorenal axis.Effect of extracts of poly(ether imide) microparticles on cytotoxicity, ROS generation and proinflammatory effects on human monocytic (THP-1) cells.Protein-bound uremic toxins: a long overlooked culprit in cardiorenal syndrome.Microbiome, trimethylamine N-oxide, and cardiometabolic disease.Cardiac actions of fibroblast growth factor 23.Constipation and Incident CKD.Role of Gut-derived Uremic Toxins on Oxidative Stress and Inflammation in Patients with Chronic Kidney Disease.Human organic anion transporters function as a high-capacity transporter for p-cresyl sulfate, a uremic toxin.Extendin-4 protects kidney from acute ischemia-reperfusion injury through upregulation of NRF2 signaling.MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4.Indoxyl Sulfate Promotes Macrophage IL-1β Production by Activating Aryl Hydrocarbon Receptor/NF-κ/MAPK Cascades, but the NLRP3 inflammasome Was Not Activated.Serum sulfatide abnormality is associated with increased oxidative stress in hemodialysis patients.Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease.Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120
P2860
Q26781300-2D354288-5501-487F-A319-C00FF03F433DQ26784008-44B3C05C-7A1D-454F-A8DF-4E79CD4596B8Q33780032-C0AE2E10-C7E0-4F60-85B3-8C325BC1B49FQ34357452-079EC91A-65AB-489B-857D-F83E41684C04Q34718513-BFDA634A-7C69-4A74-82A1-88767F0A11CFQ35033613-6054F26A-16ED-4357-91D0-0BE49D9ACB1AQ35071066-2D797CCC-F5EC-402C-80F1-AD406ADA2D05Q35364712-4B65B905-653F-4A66-8CCB-B3FFA4DD754CQ35550609-0A18C161-D052-47E1-9024-BD28FD9370CCQ35588665-8CDACAD2-B1F7-4A84-B4CB-BA0BA064447BQ35790521-C84A444D-4DC3-427A-8C89-A3F38873A3DBQ35996626-4ED21742-F8DC-42CD-AB7D-7C30C779C360Q36099390-13073BAA-269D-4A70-AFA1-7F85C49C7C41Q36168673-FBF63518-4B1A-40FF-AB56-5567408864D5Q36260141-F68B1A23-D829-469D-8CC6-2178CB32648FQ36293083-9719F698-70F0-4A9B-96EF-4374E7CAFF04Q36318399-FE17B9BF-F1E7-432F-900A-4970A9B31DE9Q36801926-3C0EE45D-C144-49AF-8469-618D359482DEQ36963471-43FBFE4C-37EC-4733-9C7C-E956A572FB0EQ37084883-A5EB8FDA-9FC4-40C3-9099-CB4B14CAEBEFQ38126800-CD4C4E59-B8AA-43E6-BA2D-CFF79A4B1473Q38180840-A83F6F10-D3DF-41C3-AD29-37209B940F3DQ38190366-7C3E08C1-724B-48F9-AF49-0608C6E185D2Q38218395-747608E6-A362-4B52-8CBE-A75552F7490BQ38267707-832E44E5-94A3-446B-8D1E-314C871F536AQ38725113-AB4FE063-C006-4F35-BD03-4250FBB445ADQ38814130-B06D23F5-D438-4578-AD7A-20E8BEA2FD9EQ38826236-E5E6F59A-127F-413B-B71F-1B7AEF1C295FQ38918147-15922259-E364-42BD-AEF9-19CF9D237FFDQ38977291-98DBFADF-E70A-40FB-97DC-B633AD3BCD68Q40364386-0FD3BEC7-8F8B-4DAA-AB83-BEEA0A7C71A5Q41514235-9F97A1B0-9729-49C1-8965-5117935D34BFQ46847494-FC8EEB67-4410-47F3-B293-5A928AD42D4DQ47099728-965D6C1F-2AA6-4DF4-902B-AE8FD662AB97Q49620885-D6708C24-966A-4026-B091-91E2DCCA558AQ52726373-79EBC5C0-959D-4A22-A579-47F1C652AEB4Q53621228-FBFEA5FF-86BC-4A43-8D65-22C25DC64AA4Q53674702-2D15C6F9-955E-4217-AF17-DF7CE26DB66DQ54000190-9E33A331-9BF2-4605-B768-AD3B33AF1B3AQ58749760-C45ADE38-1FB7-4A33-8E28-DBBF34FC9329
P2860
Cardiorenal syndrome: the emerging role of protein-bound uremic toxins
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cardiorenal syndrome: the emerging role of protein-bound uremic toxins
@ast
Cardiorenal syndrome: the emerging role of protein-bound uremic toxins
@en
Cardiorenal syndrome: the emerging role of protein-bound uremic toxins
@nl
type
label
Cardiorenal syndrome: the emerging role of protein-bound uremic toxins
@ast
Cardiorenal syndrome: the emerging role of protein-bound uremic toxins
@en
Cardiorenal syndrome: the emerging role of protein-bound uremic toxins
@nl
prefLabel
Cardiorenal syndrome: the emerging role of protein-bound uremic toxins
@ast
Cardiorenal syndrome: the emerging role of protein-bound uremic toxins
@en
Cardiorenal syndrome: the emerging role of protein-bound uremic toxins
@nl
P2093
P1433
P1476
Cardiorenal syndrome: the emerging role of protein-bound uremic toxins
@en
P2093
Bing H Wang
Darren J Kelly
Henry Krum
Suree Lekawanvijit
P304
P356
10.1161/CIRCRESAHA.112.278457
P407
P577
2012-11-01T00:00:00Z